CERS3 and mantle cell lymphoma: Research on Mantle Cell Lymphoma showed that SR141716 A blocks the CB1-mediated signaling pathway, leading to the activation of the de novo ceramide production pathway (involving enzymes CerS3 and CerS6) and resulting in cell death (K. Gustafsson et al. 2009).